Evidence map›Paper›PMID 37770972›Full record

ArticleParticle and fibre toxicology2023

Difference in carcinogenicities of two different vapor grown carbon fibers with different physicochemical characteristics induced by intratracheal instillation in rats.

Kei Sato, Hiroko Fukui, Yuji Hagiwara, Ryoji Ogawa, Ayako Nishioka, Takamasa Numano, Taiki Sugiyama, Mayumi Kawabe, Yukinori Mera, Tadashi Yoneda

Open access · goldAbstract read
In one paragraph

Article in Particle and fibre toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kei SatoChemical Management Department, Resonac Corporation, Tokyo Shiodome Bldg.,1-9-1, Higashi-Shimbashi, Minato-ku, Tokyo, 105-7325, Japan. sato.kei.xiuwy@resonac.com.
Hiroko FukuiChemical Management Department, Resonac Corporation, Tokyo Shiodome Bldg.,1-9-1, Higashi-Shimbashi, Minato-ku, Tokyo, 105-7325, Japan.
Yuji HagiwaraChemical Management Department, Resonac Corporation, Tokyo Shiodome Bldg.,1-9-1, Higashi-Shimbashi, Minato-ku, Tokyo, 105-7325, Japan.
Ryoji OgawaChemical Management Department, Resonac Corporation, Tokyo Shiodome Bldg.,1-9-1, Higashi-Shimbashi, Minato-ku, Tokyo, 105-7325, Japan.
Ayako NishiokaChemical Management Department, Resonac Corporation, Tokyo Shiodome Bldg.,1-9-1, Higashi-Shimbashi, Minato-ku, Tokyo, 105-7325, Japan.
Takamasa NumanoDIMS Institute of Medical Science, Inc., 64 Goura, Nishiazai, Azai-cho, Ichinomiya-shi, Aichi, 491-0113, Japan.
Taiki SugiyamaDIMS Institute of Medical Science, Inc., 64 Goura, Nishiazai, Azai-cho, Ichinomiya-shi, Aichi, 491-0113, Japan.
Mayumi KawabeDIMS Institute of Medical Science, Inc., 64 Goura, Nishiazai, Azai-cho, Ichinomiya-shi, Aichi, 491-0113, Japan.
Yukinori MeraDIMS Institute of Medical Science, Inc., 64 Goura, Nishiazai, Azai-cho, Ichinomiya-shi, Aichi, 491-0113, Japan.
Tadashi YonedaChemical Management Department, Resonac Corporation, Tokyo Shiodome Bldg.,1-9-1, Higashi-Shimbashi, Minato-ku, Tokyo, 105-7325, Japan.
Resonac (Japan)DIC (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarbon fibers are high aspect ratio structures with diameters on the submicron scale. Vapor grown carbon fibers are contained within multi-walled carbon tubes, with VGCF™-H commonly applied as a conductive additive in lithium-ion batteries. However, several multi-walled carbon fibers, including MWNT-7, have been reported to induce lung carcinogenicity in rats. This study investigated the carcinogenic potential of VGCF™-H fibers in F344 rats of both sexes with the vapor grown carbon fibers VGCF™-H and MWNT-7 over 2 years. The carbon fibers were administered to rats by intratracheal instillation at doses of 0, 0.016, 0.08, and 0.4 mg/kg (total doses of 0, 0.128, 0.64, and 3.2 mg/kg) once per week for eight weeks and the rats were observed for up to 2 years after the first instillation.

resultsHistopathological examination showed the induction of malignant mesothelioma on the pleural cavity with dose-dependent increases observed at 0, 0.128, 0.64, and 3.2 mg/kg in rats of both sexes that were exposed to MWNT-7. On the other hand, only two cases of pleural malignant mesothelioma were observed in the VGCF™-H groups; both rats that received 3.2 mg/kg in male. The animals in the MWNT-7 groups either died or became moribund earlier than those in the VGCF™-H groups, which is thought related to the development of malignant mesothelioma. The survival rates were higher in the VGCF™-H group, and more carbon fibers were observed in the pleural lavage fluid (PLF) of the MWNT-7 groups. These results suggest that malignant mesothelioma is related to the transfer of carbon fibers into the pleural cavity.

conclusionsThe intratracheal instillation of MWNT-7 clearly led to carcinogenicity in both male and female rats at all doses. The equivocal evidence for carcinogenic potential that was observed in male rats exposed to VGCF™-H was not seen in the females. The differences in the carcinogenicities of the two types of carbon fibers are thought due to differences in the number of carbon fibers reaching the pleural cavity. The results indicate that the carcinogenic activity of VGCF™-H is lower than that of MWNT-7.

Indexed as

Lung NeoplasmsMesothelioma, MalignantAnimalsCarbon FiberCarcinogensFemaleLungMaleRatsRats, Inbred F344Carbon FiberCarcinogens2-Year carcinogenicity studyCarbon fiberIntratracheal instillationMesotheliomaMulti-walled carbon nanotubeRatVapor grown carbon fiber

Identifiers

PMID37770972
PMCPMC10537556
OpenAlexW4387120024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.